Improves method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients

被引：7
|
作者：
Alvero, AB
Burtness, BA
Ercan, AG
Sapi, E
机构：
[1] Univ New Haven, Dept Biol & Environm Sci, West Haven, CT 06516 USA
[2] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA
来源：
LABORATORY INVESTIGATION | 2004年 / 84卷 / 05期
关键词：
breast cancer; micrometastasis; circulating tumor cells; real-time RT-PCR; cytokeratin; 19; peripheral blood;
D O I：
10.1038/labinvest.3700086
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
To determine the correlation of the levels of circulating tumor cells (CTC) in breast cancer patients with clinical parameters like disease-free survival and response to therapy, we employed a previously reported quantitative real-time reverse-transcription polymerase chain reaction (QRT-PCR) assay for cytokeratin-19 (Ck19; Ann Oncol 2001; 12: 39-46). Our preliminary results based on this assay (Protocol A) prompted us to optimize the experimental conditions. Here we report an improved assay (Protocol 13), which more sensitively and specifically detects CTC in breast cancer patients.
引用
收藏
页码：658 / 661
页数：4
相关论文
共 50 条
  • [1] Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis
    Saloustros, Emmanouil
    Mavroudis, Dimitris
    FUTURE ONCOLOGY, 2010, 6 (02) : 209 - 219
  • [2] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Agelaki, S.
    Perraki, M.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Kontopodis, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 589 - 597
  • [3] Detection of cytokeratin-19 mRNA-positive cells in peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Perraki, M.
    Agelaki, S.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 112 - 112
  • [4] Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance
    Stathopoulou, A
    Vlachonikolis, I
    Mavroudis, D
    Perraki, M
    Kouroussis, C
    Apostolaki, S
    Malamos, N
    Kakolyris, S
    Kotsakis, A
    Xenidis, N
    Reppa, D
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3404 - 3412
  • [5] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    A Daskalaki
    S Agelaki
    M Perraki
    S Apostolaki
    N Xenidis
    E Stathopoulos
    E Kontopodis
    D Hatzidaki
    D Mavroudis
    V Georgoulias
    British Journal of Cancer, 2009, 101 : 589 - 597
  • [6] A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients
    François Breton
    Bernard Bennetau
    Rosette Lidereau
    Laurent Thomas
    Gilles Regnier
    Jean-Claude Ehrhart
    Patrick Tauc
    Phuong-Lan Tran
    Biomedical Microdevices, 2011, 13 : 1 - 9
  • [7] A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients
    Breton, Francois
    Bennetau, Bernard
    Lidereau, Rosette
    Thomas, Laurent
    Regnier, Gilles
    Ehrhart, Jean-Claude
    Tauc, Patrick
    Tran, Phuong-Lan
    BIOMEDICAL MICRODEVICES, 2011, 13 (01) : 1 - 9
  • [8] Molecular detection of EGFRvIII-positive cells in the peripheral blood of breast cancer patients
    Silva, Henriqueta A. C.
    Abraul, Elsa
    Raimundo, Dulce
    Dias, Margarida F.
    Marques, Carlos
    Guerra, Carlos
    de Oliveira, Carlos F.
    Regateiro, Fernando J.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) : 2617 - 2622
  • [9] Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
    Xenidis, N
    Vlachonikolis, I
    Mavroudis, D
    Perraki, M
    Stathopoulou, A
    Malamos, N
    Kouroussis, C
    Kakolyris, S
    Apostolaki, S
    Vardakis, N
    Lianidou, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2003, 14 (06) : 849 - 855
  • [10] TO DETECT THE EXPRESSION OF CYTOKERATIN 19 IN PERIPHERAL BLOOD OF PATIENTS WITH BREAST CANCER AND ITS CLINICAL SIGNIFICANCE
    Dong, X. L.
    Huang, Y.
    Tong, Q.
    Xue, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 109 - 109
12345